Description
Ostarine (MK-2866) research SARM
Ostarine (enobosarm, MK-2866) is one of the most studied non-steroidal SARMs, with clinical research in muscle wasting associated with cancer and in other conditions.
Product details
| Compound | Ostarine (MK-2866, enobosarm, GTx-024) |
|---|---|
| Class | Selective androgen receptor modulator |
| Form | Liquid; Transdermal Liquid; Powder; Injectables; Capsules; Tablets |
| Strength | 15ml/17mg per ml/250mg; 30ml/33mg per ml/1000mg; 30ml/67mg per ml/2000mg; 60ml/33mg per ml/2000mg; 1g; 10ml/64mg per ml = 640mg; 20mg/60ct/1.2g; 15mg/35ct/525mg; 15mg/70ct/1050mg; 15mg/35ct/525mg; 15mg/70ct/1050mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Clinical research: phase 2 and 3 studies in cancer-related muscle wasting.
- Tissue selectivity: anabolic versus androgenic endpoints.
- Oncology research: AR-targeting in breast cancer studies.
Learn more in What are SARMs?
Regulatory status
This compound is not an approved medicine. The FDA has warned about serious risks from products containing SARMs and similar compounds, and these compounds are prohibited in sport by WADA. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from heat and light.
Related research products
S4 Andarine + Ostarine (MK-2866) Stack · Ostarine (MK-2866) + Cardarine (GW-501516) Stack · Sculptor (Ostarine + Andarine S4) · All SARMs
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.